| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1045695B1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease |
| 03/24/2004 | EP0758341B1 FACTOR Xa INHIBITORS |
| 03/24/2004 | EP0726953B1 Human kunitz-type protease inhibitors |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484617A Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1483782A Adhesive |
| 03/24/2004 | CN1483470A Medicinal plaster for treating anemia |
| 03/24/2004 | CN1483466A Polygonum capitatum extract and medicinal composition preparation thereof |
| 03/24/2004 | CN1483432A Clathrate compound of daemonorops draco |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142940C Pharmaceutical compsns. containing an MPL ligand |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/24/2004 | CN1142781C Use of 9-deoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'- interphenylene)-13,14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
| 03/23/2004 | US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/23/2004 | US6710031 Protein having antithrombotic activity and method for producing the same |
| 03/23/2004 | US6710028 Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron |
| 03/19/2004 | CA2440914A1 Process for sterilization of protein containing biological compositions |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022602A1 Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof |
| 03/18/2004 | WO2004022598A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022555A1 Isoxazoles and their use in the treatment of ischemic diseases |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003086563A3 Diabetes imaging probes |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003039434A3 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 03/18/2004 | WO2003011222A3 Thrombin inhibitors |
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | US20040054184 Preservative for organs, synthetic blood |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040053992 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 03/18/2004 | US20040053982 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 03/18/2004 | US20040053967 3-(3-Amidinophenyl)-5-[({[1-(1-(iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053944 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053918 Erythropoietin production potentiator |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053869 Stem cell differentiation |
| 03/18/2004 | US20040053852 Preventing desensitization of receptors |
| 03/18/2004 | US20040053851 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |
| 03/18/2004 | US20040053828 Partial peptide mimetics and methods |
| 03/18/2004 | US20040053820 Histone deacetylase inhibitor |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040052870 Cyclooxygenase (COX-2) inhibitors; for treatment/prevention of inflammation; nutraceuticals; for treatment of nervous system disorders |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040050784 Method for the manufacture of compositions containing low concentrations of salts |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398324A1 Use of recombinant gelatin-like proteins as plasma expanders and compositions suitable for plasma substitution |
| 03/17/2004 | EP1398036A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/17/2004 | EP1397364A1 Novel pyrrole derivatives as pharmaceutical agents |
| 03/17/2004 | EP1397361A1 Carboline derivatives as pdev inhibitors |
| 03/17/2004 | EP1397356A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397355A1 Pyridyl cyanoguanidine compounds |
| 03/17/2004 | EP1397354A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 03/17/2004 | EP1397351A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/17/2004 | EP1397348A2 Factor xa inhibitor |
| 03/17/2004 | EP1397341A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397167A2 Wound closure system and methods |
| 03/17/2004 | EP1397153A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397148A2 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 03/17/2004 | EP1397139A1 Pharmaceutical combinations |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1397130A1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 03/17/2004 | EP1397128A1 Kappa opiate agonists for the treatment of bladder diseases |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1140839B1 Heterocyclic amides as inhibitors of factor xa |
| 03/17/2004 | EP1140820B1 New amidino derivatives and their use as thrombin inhibitors |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1482919A Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
| 03/17/2004 | CN1482139A Mucroslysin protein and gene thereof |